JNBA Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.27M | Sell |
9,004
-18
| -0.2% | -$3.87K | 0.17% | 64 |
|
|
2026
Q1 | $1.96M | Sell |
9,022
-179
| -2% | -$39.7K | 0.16% | 67 |
|
|
2025
Q4 | $2.1M | Sell |
9,201
-172
| -2% | -$39.2K | 0.18% | 62 |
|
|
2025
Q3 | $2.17M | Buy |
9,373
+77
| +0.8% | +$15.7K | 0.2% | 62 |
|
|
2025
Q2 | $1.73M | Hold |
9,296
| – | – | 0.17% | 68 |
|
|
2025
Q1 | $1.95M | Buy |
9,296
+225
| +2% | +$43.7K | 0.2% | 59 |
|
|
2024
Q4 | $1.61M | Sell |
9,071
-26
| -0.3% | -$4.78K | 0.16% | 68 |
|
|
2024
Q3 | $1.8M | Hold |
9,097
| – | – | 0.18% | 62 |
|
|
2024
Q2 | $1.56M | Buy |
9,097
+120
| +1% | +$19.9K | 0.16% | 70 |
|
|
2024
Q1 | $1.63M | Sell |
8,977
-231
| -3% | -$39.8K | 0.17% | 73 |
|
|
2023
Q4 | $1.43M | Buy |
9,208
+66
| +0.7% | +$9.62K | 0.16% | 83 |
|
|
2023
Q3 | $1.36M | Sell |
9,142
-235
| -3% | -$34.5K | 0.17% | 79 |
|
|
2023
Q2 | $1.26M | Buy |
9,377
+30
| +0.3% | +$4.4K | 0.15% | 84 |
|
|
2023
Q1 | $1.49M | Sell |
9,347
-376
| -4% | -$57.5K | 0.19% | 77 |
|
|
2022
Q4 | $1.57M | Sell |
9,723
-319
| -3% | -$48.9K | 0.22% | 71 |
|
|
2022
Q3 | $1.35M | Sell |
10,042
-162
| -2% | -$23.2K | 0.21% | 75 |
|
|
2022
Q2 | $1.56M | Buy |
10,204
+71
| +0.7% | +$10.8K | 0.24% | 68 |
|
|
2022
Q1 | $1.64M | Sell |
10,133
-563
| -5% | -$81.8K | 0.22% | 70 |
|
|
2021
Q4 | $1.45M | Sell |
10,696
-165
| -2% | -$19.5K | 0.18% | 78 |
|
|
2021
Q3 | $1.17M | Hold |
10,861
| – | – | 0.16% | 85 |
|
|
2021
Q2 | $1.22M | Hold |
10,861
| – | – | 0.17% | 82 |
|
|
2021
Q1 | $1.18M | Buy |
10,861
+256
| +2% | +$27.4K | 0.17% | 79 |
|
|
2020
Q4 | $1.14M | Buy |
10,605
+44
| +0.4% | +$4.23K | 0.19% | 76 |
|
|
2020
Q3 | $925K | Sell |
10,561
-50
| -0.5% | -$4.71K | 0.19% | 78 |
|
|
2020
Q2 | $1.04M | Buy |
10,611
+37
| +0.3% | +$3.26K | 0.22% | 72 |
|
|
2020
Q1 | $806K | Buy |
10,574
+310
| +3% | +$26.4K | 0.19% | 77 |
|
|
2019
Q4 | $909K | Hold |
10,264
| – | – | 0.17% | 81 |
|
|
2019
Q3 | $777K | Sell |
10,264
-290
| -3% | -$19.9K | 0.16% | 81 |
|
|
2019
Q2 | $768K | Buy |
10,554
+293
| +3% | +$23K | 0.16% | 80 |
|
|
2019
Q1 | $827K | Sell |
10,261
-51
| -0.5% | -$4.17K | 0.18% | 73 |
|
|
2018
Q4 | $951K | Buy |
10,312
+260
| +3% | +$22.9K | 0.22% | 59 |
|
|
2018
Q3 | $951K | Sell |
10,052
-123
| -1% | -$11.7K | 0.43% | 56 |
|
|
2018
Q2 | $943K | Hold |
10,175
| – | – | 0.2% | 56 |
|
|
2018
Q1 | $963K | Sell |
10,175
-100
| -1% | -$11K | 0.21% | 54 |
|
|
2017
Q4 | $994K | Sell |
10,275
-570
| -5% | -$53.7K | 0.21% | 53 |
|
|
2017
Q3 | $964K | Sell |
10,845
-1,526
| -12% | -$116K | 0.22% | 49 |
|
|
2017
Q2 | $897K | Buy |
12,371
+2
| +0% | +$134 | 0.2% | 49 |
|
|
2017
Q1 | $806K | Buy |
12,369
+2
| +0% | +$126 | 0.19% | 56 |
|
|
2016
Q4 | $774K | Buy |
12,367
+2,628
| +27% | +$160K | 0.19% | 54 |
|
|
2016
Q3 | $614K | Sell |
9,739
-2,233
| -19% | -$145K | 0.09% | 80 |
|
|
2016
Q2 | $741K | Buy |
11,972
+200
| +2% | +$12.2K | 0.21% | 49 |
|
|
2016
Q1 | $672K | Hold |
11,772
| – | – | 0.24% | 50 |
|
|
2015
Q4 | $697K | Buy |
11,772
+980
| +9% | +$56.4K | 0.27% | 44 |
|
|
2015
Q3 | $587K | Buy |
10,792
+1,495
| +16% | +$97.3K | 0.25% | 44 |
|
|
2015
Q2 | $625K | Hold |
9,297
| – | – | 0.24% | 45 |
|
|
2015
Q1 | $544K | Hold |
9,297
| – | – | 0.21% | 48 |
|
|
2014
Q4 | $608K | Sell |
9,297
-150
| -2% | -$9.46K | 0.25% | 46 |
|
|
2014
Q3 | $546K | Buy |
9,447
+365
| +4% | +$20.3K | 0.25% | 48 |
|
|
2014
Q2 | $513K | Hold |
9,082
| – | – | 0.25% | 51 |
|
|
2014
Q1 | $467K | Sell |
9,082
-1,330
| -13% | -$67.2K | 0.25% | 52 |
|
|
2013
Q4 | $550K | Buy |
10,412
+581
| +6% | +$28.6K | 0.3% | 45 |
|
|
2013
Q3 | $440K | Sell |
9,831
-2,092
| -18% | -$92.7K | 0.27% | 54 |
|
|
2013
Q2 | $493K | Buy |
+11,923
| New | +$521K | 0.34% | 44 |
|
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
JNBA Financial Advisors's ABBV Position: Q2 2026 in Review
JNBA Financial Advisors reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $3.87K and leaving 9,004 shares worth $2.27M. The position accounts for 0.17% of the portfolio, ranked #64.
JNBA Financial Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,576 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- JNBA Financial Advisors held 9,004 shares of AbbVie worth $2.27M as of Q2 2026.
- JNBA Financial Advisors sold 18 AbbVie shares in Q2 2026, an estimated $3.87K.
- AbbVie made up 0.17% of JNBA Financial Advisors's portfolio in Q2 2026, its #64 holding.
- JNBA Financial Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,576 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.